Cargando…

Mechanisms and biomarkers of immune-related adverse events in gastric cancer

Immune-checkpoint inhibitors (ICIs), different from traditional cancer treatment models, have shown unprecedented anti-tumor effects in the past decade, greatly improving the prognosis of many malignant tumors in clinical practice. At present, the most widely used ICIs in clinical immunotherapy for...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Ping’an, Liu, Pengpeng, Meng, Lingjiao, Zhao, Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631148/
https://www.ncbi.nlm.nih.gov/pubmed/37936161
http://dx.doi.org/10.1186/s40001-023-01365-3